The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11113 malaria professionals are enjoying the free benefits of MalariaWorld today

Miles Markus's blog

Vivax and Non-vivax Malaria: Elimination-related Research Agenda Items

September 3, 2016 - 22:59 -- Miles Markus

The presumed hypnozoite reservoir is perceived to be a threat to the goal of eradicating human malaria. However, the same now applies to putative non-hypnozoite tissue stages as well, notably quiescent merozoites. Persistence of extra-vascular tissue merozoites in vivax malaria has on genetic grounds been suspected since 2011. So far, they have been parasitologically demonstrated in rodent malarial infections. There is no particular reason why they should not also occur in primate malaria of various kinds.

Problems with the Hypnozoite Theory of Relapse

July 24, 2016 - 00:12 -- Miles Markus

Speculative extrapolation from biological and genetic findings resulting from malarial research carried out in recent years, places in doubt aspects of the validity of the current concept of hypnozoite-mediated malarial relapse, entrenched though the hypothesis (usually stated by authors as a fact) is. A piece(s) of the puzzle might be missing.

Discussed in detail here

Elaborated upon further here

Malaria Elimination Dilemma

July 13, 2016 - 22:02 -- Miles Markus

A little waterbird (or was it a frog?) whispered in my ear. Aquatic organisms don’t want humans to destroy their habitats when trying to eliminate malaria. Draining of swamps, for example, would have negative consequences not only for mosquitoes but also for various other (innocent) creatures that live there. Where does this leave malariologists, so to speak? Just asking.

Plasmodium vivax: Drug-induced Dormancy?

May 12, 2016 - 13:28 -- Miles Markus

Early recurrences (which are often homologous) in treated Plasmodium vivax infections are usually considered to be hypnozoite-mediated relapses. Can such recurrences sometimes or frequently be, instead, recrudescences caused by reactivation of blood stages that became temporarily quiescent following drug exposure? The experimental background to this question is given here.

Primaquine Not "Working"

May 5, 2016 - 14:02 -- Miles Markus

Therapeutic failure of primaquine in cases of Plasmodium vivax malaria is often noted by clinicians. A newly recognized, possible cause of such treatment failure is the reactivation of viable dormant parasites that might be present in one or more extra-hepatic and extra-vascular sites. Administration of primaquine will not necessarily result in these stages being killed. Here is the link to where this drug-associated matter is discussed.

Does Plasmodium malariae have a hypnozoite stage?

March 30, 2016 - 19:50 -- Miles Markus

COMMENT: For many years, it has traditionally been considered that Plasmodium malariae does not have a hypnozoite stage in its life cycle. Evidence for this has been thought to perhaps include the longevity of hepatocytes and what happens after inoculation of parasitized erythrocytes into the primate host (see hepatocyte and P. malariae sections, respectively). More recently, there have been suggestions that hypnozoites might, in fact, be present in the liver in P.

Pages

Subscribe to RSS - Miles Markus's blog